Atlas Maps Overlooked Microproteins in Alzheimer's-Affected Human Brain Tissue

What the study found

Researchers analyzed frontal cortex tissue from more than 600 postmortem samples from people with and without Alzheimer's disease. Using transcriptomics, mass spectrometry and computational prediction, they identified 1,067 previously unannotated microproteins. A subset showed different expression in Alzheimer's disease tissue compared with unaffected tissue, independent of nearby annotated genes.

What it means. One microprotein, a 63-amino-acid product of the MKKS gene, was reduced in Alzheimer's disease samples. In laboratory experiments, loss of this microprotein impaired mitochondrial respiration in microglial cells, pointing to a possible role in their energy metabolism. The atlas expands the known brain proteome and offers a resource for further study, without establishing that these microproteins cause or worsen Alzheimer's disease.

What to watch. These findings come from postmortem tissue and laboratory cell experiments, not from living patients or clinical outcomes. It is unclear whether the microglial effects extend beyond the cell models used, or whether the observed changes reflect a cause or consequence of Alzheimer's-related brain changes. The result is described as an early, developing signal.